1.      Subramanian S, Tumlin J, Bapat B, Nikolsky E, Mehran R, Turcot DB, et al.Impact of chronic kidney disease on prognosis by the Society of Critical Care.   Crit Care Med 2008; 36:S204-S211.

2.      Drey N, Roderick P, Mullee M, Rogerson M. A population based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 2003; 42: 677–84.

3.      McCullough PA. Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med 2002; 3:71– 6.

4.      Pepys MB, Gill R, Kemp JA, Sabin C. CRP or not CRP? That is the question. ArteriosclerThrombVasc Biol. 2005; 25: 1091–4.

5.      Arici M, Walls J. end stage renal disease, atherosclerosis and cardiovascular mortality: is C-reactive protein the missing link?  Kidney Int 2001; 59: 407-14

6.      Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323:27-36.

7.      Vane JR, Botting RM. Formation by the endothelium of prostacyclin, nitric oxide and endothelin. J Lipid Mediat 1993;6:395– 404.

8.      Frick M, Weidinger F. Endothelial function: A surrogate endpoint in cardiovascular studies? Curr Pharm Des 2007; 13:1741–50.

9.      Werner N , Kosiol S , Schiegl T ,Ahlers P ,Walenta K ,Link A et al . Circulating endothelial progenitor cells and cardiovascular outcome. N Engl J Med 2005; 353:999-1007.

10.  Koc M, Bihorac A, Segal MS. Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients. Am J Kidney Dis 2003; 42:704-12.

11.  Mutin M, Canavy I, Blann A, Bory M, Sampol J, Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999;93:2951-8.

12.  Makin A , Chung NAY , Silverman SH , Blann A, Lip GY. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Eur Heart J 2004:25; 371-6.

13.  Goon PKY Boos CJ, and Lip GYH. Circulating endothelial cells: markers of vascular dysfunction. Clin Lab 2005; 51, 531 – 8.

14.  Furstenberger G , von Moos R , Lucas R , Thurlimann B, Senn HJ , Hamacher J , Boneberg EM. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer.Br J Cancer. 2006; 94:524 –31.

15.  Bain BJ, Lewis SM, Bates M.  Basic hematological techniques. In: Bain BJ, Lewis SM, Bates I eds. Dacie and Lewis practical Hematology 10th ed. Philadelphia: Churchill Livingstone Elsevier 2006; 25-57.

16.  Dignat-George F, Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol 2000; 65:215–20.

17.  Leslie E, Geoffrey J, James M (eds). Statistical analysis. In: Interpretation and uses of medical statistics (4th ed). Oxford Scientific Publications (pub). 1991, pp.411-6.

18.  Parfrey P. Is renal insufficiency an atherogenic state? Reflections on prevalence, incidence and risk. Am J Kidney Dis 2001; 37:154–7.

19.  Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296–305.

20.  Owen FO, Lowrie EG, C reactive protein as an outcome predictor in maintenance haemodialysis patients Kidney Int 1998; 54:627-36.

21.  ChristophWanner, Josef Zimmermann, Susanne Schwedler, Thomas Metzger. Inflammation and cardiovascular risk in dialysis patients Kid Int 2002; 61( Suppl 80): S99–S102.

22.  Koc M, Bihorac A, Segal MS. Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients. Am J Kidney Dis 2003; 42:704-12.

23.  HerbrigK ,Pistrosch F , Oelschlaegel U ,Wichmann G , Wagner A , Foerester S .increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long term haemodialysis . Am J Kidney Dis 2004;44: 890-4.

24.  Eizawa TMY, Matsui K, Takahashi M, Muroi K, Amemiya M, Takano R  et al. circulating endothelial progenitor cells are reduced in haemodialysis patients .Curr Med Res Opin 2003;19: 627-33.

25.  Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W et al .decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler ThrombVascBiol 2004; 24:1246-52.

26.  Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA et al. circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.

27.  Rodriguez Ayala E , Yao  Q, Holmen C , Lindholm B , Sumitran – Holgersson S , Stenvinkel P. embalance between detached circulating endothelial cells and endothelial progenitor cells in chronic kidney Disease . Blood Purif 2005;24:196-202.

28.  Westerweel PE , Hoefer IE ,  Blankestijin PJ , De Bree P ,Groenveld D , Oostrom O et al . End stage renal disease cause embalance between endothelial and smooth muscles progenitor cells .Am J Renal Physiol 2007; 292:F1132-F40.

29.  Mehmet Koc, Hanno B. Richards, AzraBihorac, Edward A. Ross, Jesse D. Schold, and Mark S. Segal Circulating endothelial cells are associated with future vascular events in hemodialysis patients Kidney Int 2005; 67: 1078–83.

30.  George F, Brisson C, Poncelet P, Laurent JC, Massot O, Arnoux D et al. Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty. ThrombHaemost 1992; 67:147-53.

31.  Goon PKY Boos CJ, and Lip GYH. Circulating endothelial cells: markers of vascular dysfunction. Clin Lab 2005; 51, 531 – 8.

32.  Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am SocNephrol. 2002; 13:745–753.

33.  Wang C, Li H, Fu P, Zhang S, Xiu R. Serum C-reactive protein and circulating endothelial cells in patients with acute myocardial infarction. ClinHemorheol Microcirc 2005; 32:287–96.